Literature DB >> 10975609

Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.

S Ramachandran1, P R Hoban, F Ichii-Jones, L Pleasants, F Ali-Osman, J T Lear, A G Smith, B Bowers, P W Jones, A A Fryer, R C Strange.   

Abstract

We previously described associations between basal cell carcinoma (BCC) numbers and allelic variants at loci that mediate host response to ultraviolet radiation (UV). These associations were largely exerted in cases with the multiple presentation phenotype (MPP). This phenotype describes patients who present at their first or a later presentation with a cluster of BCC (2-10 new BCC). Remaining BCC cases have the single presentation phenotype (SPP) and may develop more than one BCC but only have single new lesions at any presentation. We proposed that the MPP cases comprise a high-risk group as they suffer significantly more lesions than SPP cases. We are attempting to determine, in the total BCC case group and subgroups, how many genes influence BCC numbers and their relative importance. In this study, we assessed the influence of two further candidates, glutathione S-transferase GSTP1 and cyclin D1 (CCND1), on tumour numbers in a total group of 457 patients comprising MPP and SPP cases. The relative importance of these genes in comparison with occupational UV exposure and host response (skin type) was also considered. We found that the frequencies of GSTP1 genotypes based on the Ile105 and Val105-expressing alleles and CCND1 AA, AG, GG genotypes were similar in MPP and SPP cases and that there were no significant associations between GSTP1 or CCND1 genotypes and BCC numbers in the total or SPP groups. However, in the MPP cases, GSTP1 Val105/Val105 was associated with more tumours (P = 0.05, reference GSTP1 Ile105/Ile105). Inclusion of skin type and indoor/outdoor occupation in the negative binomial regression models did not alter the associations of these genotypes with tumour numbers. DNA from 258 cases was analysed to identify GSTP1*A (Ile105-Ala114), GSTP1*B (Val105-Ala114), GSTP1*C (Val105-Val114) and GSTP1*D (Ile105-Val114). In SPP cases, there was no association between BCC numbers and GSTP1 BB, though the association with GSTP1 BC approached significance (P = 0.09). In MPP cases, GSTP1 BC was associated with BCC numbers (P = 0.03). We also found that the interaction term, GSTP1 Val105/Val105 with CCND1 AA, was associated with BCC numbers in the total (P = 0.001) and MPP (P = 0.006) but not SPP (P = 0.68) groups. In a stepwise model including GSTP1 Val105/Val105, CCND1 AA and their interaction terms as well as GSTM1, GSTT1 and CYP2D6 genotypes, skin type 1 and gender, the combination of genotypes was the best predictor of BCC numbers. These data suggest that study of further genes involved in cell-cycle control and protection from oxidative stress will be useful, particularly in high-risk subgroups.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975609     DOI: 10.1097/00008571-200008000-00008

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  9 in total

1.  Common Variants Affecting Susceptibility to Develop Multiple Basal Cell Carcinomas.

Authors:  Joris A C Verkouteren; Luba M Pardo; André G Uitterlinden; Albert Hofman; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2015-03-24       Impact factor: 8.551

2.  ASIP genetic variants and the number of non-melanoma skin cancers.

Authors:  Wen Lin; Abrar A Qureshi; Peter Kraft; Hongmei Nan; Qun Guo; Frank B Hu; Majken K Jensen; Jiali Han
Journal:  Cancer Causes Control       Date:  2011-01-09       Impact factor: 2.506

3.  Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.

Authors:  X R Yang; R M Pfeiffer; A M Goldstein
Journal:  J Med Genet       Date:  2006-04       Impact factor: 6.318

4.  Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Hao Peng; Quanyong He; Jie Zhu; Cheng Peng
Journal:  Tumour Biol       Date:  2012-11-27

5.  Simultaneous identification of GSTP1 Ile105-->Val105 and Ala114-->Val114 substitutions using an amplification refractory mutation system polymerase chain reaction assay: studies in patients with asthma.

Authors:  A Hemmingsen; A A Fryer; M Hepple; R C Strange; M A Spiteri
Journal:  Respir Res       Date:  2001-06-11

6.  Lack of association of glutathione S-transferase P1 Ile105Val polymorphism with aspirin-intolerant asthma.

Authors:  Jung-Mi Oh; Seung-Hyun Kim; Chang-Hee Suh; Dong-Ho Nahm; Hae-Sim Park; Young-Mok Lee; June-Hyuk Lee; Choon-Sik Park; Hyung-Doo Shin
Journal:  Korean J Intern Med       Date:  2005-09       Impact factor: 2.884

7.  Genetic polymorphism of glutathione S-transferase P1 (GSTP1) in Delhi population and comparison with other global populations.

Authors:  Anita Sharma; Arvind Pandey; Shashi Sharma; Indranil Chatterjee; Ravi Mehrotra; Ashok Sehgal; Joginder K Sharma
Journal:  Meta Gene       Date:  2014-01-20

8.  Evaluation of the potential nephrotoxicity and mechanism in rats after long-term exposure to the traditional Tibetan medicine tsothel.

Authors:  Li Xiang; Bo Lin; Ping Wang; Yingfan Hu; Jiasi Wu; Yong Zeng; Xianli Meng
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

9.  The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People

Authors:  Gholamreza Shahsavari; Ali Amiri; Masoud Shamaei; Glavizh Adibhesami; Amirnader Emami Razavi; Mehdi Birjandi; Mihan Pourabdollah
Journal:  Asian Pac J Cancer Prev       Date:  2019-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.